Pardes Biosciences Inc (PRDS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 3,510 | 3,670 | 4,630 | 7,000 | 7,870 |
| TOTAL | $3,510 | $3,670 | $4,630 | $7,000 | $7,870 |
| Non-Current Assets | |||||
| PPE Net | 6,040 | 6,330 | 9,240 | 11,630 | 10,490 |
| Investments And Advances | 0 | 0 | 0 | 1,000 | 1,000 |
| Other Non-Current Assets | 37,370 | 37,560 | 41,430 | 106,050 | 109,510 |
| TOTAL | $43,410 | $43,890 | $50,670 | $118,680 | $121,000 |
| Total Assets | $46,920 | $47,560 | $55,300 | $125,680 | $128,870 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,990 | 5,450 | 6,110 | 3,880 | 3,020 |
| Accrued Expenses | 9,350 | 11,450 | 10,000 | 15,230 | 9,720 |
| Other current liabilities | 430 | 330 | 1,750 | 3,880 | 4,190 |
| TOTAL | $13,840 | $17,320 | $17,950 | $23,100 | $17,390 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3 | 3 | 0 | 0 | 0 |
| TOTAL | $233 | $213 | $3,410 | $3,960 | $4,030 |
| Total Liabilities | $14,073 | $17,533 | $21,360 | $27,060 | $21,420 |
| Shareholders' Equity | |||||
| Common Shares | 30 | 30 | 30 | 30 | 30 |
| Other shareholders' equity | 310 | -110 | -150 | -550 | -750 |
| TOTAL | $230,480 | $229,320 | $229,430 | $228,940 | $228,030 |
| Total Liabilities And Equity | $244,553 | $246,853 | $250,790 | $256,000 | $249,450 |